Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade

Renal denervation – where do we stand in 2014?

Recently, resistant hypertension has received a significant amount of attention, due to its high prevalence among treated hypertensive patients as well as controversies regarding appropriate diagnostics and the development of successful treatment methods. Current results suggest that patients with resistant hypertension are at a higher risk of cardiovascular events and end-organ damage compared...

Feedback consistency effects in visual and auditory word recognition: where do we stand after more than a decade?

The role of phonology-to-spelling consistency (i.e., feedback consistency) was investigated in 3 lexical decision experiments in both the visual and auditory modalities in French and English. No evidence for a feedback consistency effect was found in the visual modality, either in English or in French, despite the fact that consistency was manipulated for different kinds of units (onsets and ri...

[Renal sympathetic denervation in resistant hypertension].

Resistant hypertension remains a major clinical problem despite the available multidrug therapy. Over the next decades, its incidence will likely increase given that it is strongly associated with older age and obesity. Resistant hypertension patients have an increased cardiovascular risk, thus effective antihypertensive treatment will provide substantial health benefits. The crosstalk between ...

Masked hypertension: where do we stand?

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...